Answers are grounded in this paper and cite their sources.
Using two independent cohorts and a clinical trial population, we validated an updated KidneyIntelX test (named kidneyintelX.dkd), which significantly enhanced risk stratification in patients with DKD for PDKF, independently from known risk factors for progression.
No takes yet. Share an insight, caveat, or question.
Nadkarni et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: